Human trials by Serum Institute, India for COVID-19 vaccine by year-end

Adar Poonawala, CEO of Serum Institute, India says COVID-19 vaccine can enter human trial by the end of 2020. The World Health Organisation (WHO) says that it will take at least 18 months for the vaccine to be ready. According to WHO, as of March 20, there are more than 40 vaccine candidates in various stages of development. The SARS-nCoV-2 is an aggressive virus. About 3% of cases die, but it infects other people at a deadly rate. This is what makes the vaccine deadly. Pune-based Serum Institute of India has Codagenix, an American biotechnology firm to develop a COVID-19 vaccine. Adar Poonawala, CEO of Serum Institute of India informed that it usually takes 6-7 years to develop a vaccine. However, human trials will be possible by the year end as the company is entering into the animal trials. They have also tried to make a vector vaccine using the Measles Schwartz strains with another company in the United states (3-4 months behind the Codagenix project). They will be simultaneously testing these two vaccine candidates and hope to start animal trials soon. 

To know more about origin, virology of COVID-19, Click here

To know more about emerging themes in COVID-19, Click here

To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com

Want to set up an online consultation for your practice, Click here

https://theprint.in/health/20-indian-institutes-working-to-find-covid-19-vaccine-iits-focused-on-portable-ventilators/389037/